XYZ Color Sensors
XYZ Color Sensors market is segmented by region (country), players, by Type and by Application. P ... Read More
Global and United States Adoptive Cellular Immunotherapy Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Adoptive Cellular Immunotherapy Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Adoptive Cellular Immunotherapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Adoptive Cellular Immunotherapy Market Size for the Year 2017-2028
1.2.2 Global Adoptive Cellular Immunotherapy Market Size for the Year 2017-2028
1.3 Adoptive Cellular Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Adoptive Cellular Immunotherapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Adoptive Cellular Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Adoptive Cellular Immunotherapy Market Dynamics
1.4.1 Adoptive Cellular Immunotherapy Industry Trends
1.4.2 Adoptive Cellular Immunotherapy Market Drivers
1.4.3 Adoptive Cellular Immunotherapy Market Challenges
1.4.4 Adoptive Cellular Immunotherapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Adoptive Cellular Immunotherapy by Type
2.1 Adoptive Cellular Immunotherapy Market Segment by Type
2.1.1 TIL
2.1.2 LAK
2.1.3 CAR-T
2.1.4 TCR-T
2.1.5 CIK
2.1.6 NK
2.1.7 DC
2.1.8 Other
2.2 Global Adoptive Cellular Immunotherapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Adoptive Cellular Immunotherapy Market Size by Type (2017-2028)
2.4 United States Adoptive Cellular Immunotherapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Adoptive Cellular Immunotherapy Market Size by Type (2017-2028)
3 Adoptive Cellular Immunotherapy by Application
3.1 Adoptive Cellular Immunotherapy Market Segment by Application
3.1.1 Hospital
3.1.2 Cancer Hospital
3.1.3 Centers for Disease Control and Prevention
3.1.4 Rehabilitation Center
3.1.5 Other
3.2 Global Adoptive Cellular Immunotherapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Adoptive Cellular Immunotherapy Market Size by Application (2017-2028)
3.4 United States Adoptive Cellular Immunotherapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Adoptive Cellular Immunotherapy Market Size by Application (2017-2028)
4 Global Adoptive Cellular Immunotherapy Competitor Landscape by Company
4.1 Global Adoptive Cellular Immunotherapy Market Size by Company
4.1.1 Top Global Adoptive Cellular Immunotherapy Companies Ranked by Revenue (2021)
4.1.2 Global Adoptive Cellular Immunotherapy Revenue by Player (2017-2022)
4.2 Global Adoptive Cellular Immunotherapy Concentration Ratio (CR)
4.2.1 Adoptive Cellular Immunotherapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Adoptive Cellular Immunotherapy in 2021
4.2.3 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Adoptive Cellular Immunotherapy Headquarters, Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Adoptive Cellular Immunotherapy Headquarters and Area Served
4.3.2 Global Adoptive Cellular Immunotherapy Companies Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Adoptive Cellular Immunotherapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Adoptive Cellular Immunotherapy Market Size by Company
4.5.1 Top Adoptive Cellular Immunotherapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Adoptive Cellular Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Adoptive Cellular Immunotherapy Market Size by Region
5.1 Global Adoptive Cellular Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Adoptive Cellular Immunotherapy Market Size by Region (2017-2028)
5.2.1 Global Adoptive Cellular Immunotherapy Market Size by Region: 2017-2022
5.2.2 Global Adoptive Cellular Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Adoptive Cellular Immunotherapy Market Size YoY Growth 2017-2028
6.1.2 North America Adoptive Cellular Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Adoptive Cellular Immunotherapy Market Size YoY Growth 2017-2028
6.3.2 Europe Adoptive Cellular Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Adoptive Cellular Immunotherapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Adoptive Cellular Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Adoptive Cellular Immunotherapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Adoptive Cellular Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen Inc
7.1.1 Amgen Inc Company Details
7.1.2 Amgen Inc Business Overview
7.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
7.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.1.5 Amgen Inc Recent Development
7.2 Autolus Therapeutics Plc
7.2.1 Autolus Therapeutics Plc Company Details
7.2.2 Autolus Therapeutics Plc Business Overview
7.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
7.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.2.5 Autolus Therapeutics Plc Recent Development
7.3 Beijing Immunochina Medical Science & Technology Co Ltd
7.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
7.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
7.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
7.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
7.4 Bellicum Pharmaceuticals Inc
7.4.1 Bellicum Pharmaceuticals Inc Company Details
7.4.2 Bellicum Pharmaceuticals Inc Business Overview
7.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
7.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.4.5 Bellicum Pharmaceuticals Inc Recent Development
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Company Details
7.5.2 Bristol-Myers Squibb Co Business Overview
7.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
7.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.5.5 Bristol-Myers Squibb Co Recent Development
7.6 bluebird bio Inc
7.6.1 bluebird bio Inc Company Details
7.6.2 bluebird bio Inc Business Overview
7.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
7.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.6.5 bluebird bio Inc Recent Development
7.7 CARsgen Therapeutics Ltd
7.7.1 CARsgen Therapeutics Ltd Company Details
7.7.2 CARsgen Therapeutics Ltd Business Overview
7.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
7.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.7.5 CARsgen Therapeutics Ltd Recent Development
7.8 Celgene Corp
7.8.1 Celgene Corp Company Details
7.8.2 Celgene Corp Business Overview
7.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
7.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.8.5 Celgene Corp Recent Development
7.9 Cell Medica Ltd
7.9.1 Cell Medica Ltd Company Details
7.9.2 Cell Medica Ltd Business Overview
7.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
7.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.9.5 Cell Medica Ltd Recent Development
7.10 Cellular Biomedicine Group Inc
7.10.1 Cellular Biomedicine Group Inc Company Details
7.10.2 Cellular Biomedicine Group Inc Business Overview
7.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
7.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.10.5 Cellular Biomedicine Group Inc Recent Development
7.11 Celularity Inc
7.11.1 Celularity Inc Company Details
7.11.2 Celularity Inc Business Overview
7.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
7.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.11.5 Celularity Inc Recent Development
7.12 Celyad SA
7.12.1 Celyad SA Company Details
7.12.2 Celyad SA Business Overview
7.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
7.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.12.5 Celyad SA Recent Development
7.13 Daiichi Sankyo Co Ltd
7.13.1 Daiichi Sankyo Co Ltd Company Details
7.13.2 Daiichi Sankyo Co Ltd Business Overview
7.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
7.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.13.5 Daiichi Sankyo Co Ltd Recent Development
7.14 Fosun Pharmaceutical AG
7.14.1 Fosun Pharmaceutical AG Company Details
7.14.2 Fosun Pharmaceutical AG Business Overview
7.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
7.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.14.5 Fosun Pharmaceutical AG Recent Development
7.15 Gilead Sciences Inc
7.15.1 Gilead Sciences Inc Company Details
7.15.2 Gilead Sciences Inc Business Overview
7.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
7.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.15.5 Gilead Sciences Inc Recent Development
7.16 Guangzhou Anjie Biomedical Technology Co Ltd
7.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
7.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
7.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
7.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
7.17 Hangzhou Converd Co Ltd
7.17.1 Hangzhou Converd Co Ltd Company Details
7.17.2 Hangzhou Converd Co Ltd Business Overview
7.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
7.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.17.5 Hangzhou Converd Co Ltd Recent Development
7.18 Hebei Senlang Biotechnology Inc Ltd
7.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
7.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
7.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
7.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
7.19 HRAIN Biotechnology Co Ltd
7.19.1 HRAIN Biotechnology Co Ltd Company Details
7.19.2 HRAIN Biotechnology Co Ltd Business Overview
7.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
7.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.19.5 HRAIN Biotechnology Co Ltd Recent Development
7.20 Juno Therapeutics Inc
7.20.1 Juno Therapeutics Inc Company Details
7.20.2 Juno Therapeutics Inc Business Overview
7.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
7.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.20.5 Juno Therapeutics Inc Recent Development
7.21 Kite Pharma Inc
7.21.1 Kite Pharma Inc Company Details
7.21.2 Kite Pharma Inc Business Overview
7.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
7.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.21.5 Kite Pharma Inc Recent Development
7.22 Nanjing Legend Biotech Co Ltd
7.22.1 Nanjing Legend Biotech Co Ltd Company Details
7.22.2 Nanjing Legend Biotech Co Ltd Business Overview
7.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
7.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.22.5 Nanjing Legend Biotech Co Ltd Recent Development
7.23 NantKwest Inc
7.23.1 NantKwest Inc Company Details
7.23.2 NantKwest Inc Business Overview
7.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
7.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.23.5 NantKwest Inc Recent Development
7.24 Nkarta Inc
7.24.1 Nkarta Inc Company Details
7.24.2 Nkarta Inc Business Overview
7.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
7.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.24.5 Nkarta Inc Recent Development
7.25 Novartis AG
7.25.1 Novartis AG Company Details
7.25.2 Novartis AG Business Overview
7.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
7.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.25.5 Novartis AG Recent Development
7.26 Ono Pharmaceutical Co Ltd
7.26.1 Ono Pharmaceutical Co Ltd Company Details
7.26.2 Ono Pharmaceutical Co Ltd Business Overview
7.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
7.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.26.5 Ono Pharmaceutical Co Ltd Recent Development
7.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
7.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
7.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
7.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
7.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
7.28 Sorrento Therapeutics Inc
7.28.1 Sorrento Therapeutics Inc Company Details
7.28.2 Sorrento Therapeutics Inc Business Overview
7.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
7.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.28.5 Sorrento Therapeutics Inc Recent Development
7.29 Takara Bio Inc
7.29.1 Takara Bio Inc Company Details
7.29.2 Takara Bio Inc Business Overview
7.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
7.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022)
7.29.5 Takara Bio Inc Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Adoptive Cellular Immunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Adoptive Cellular Immunotherapy Market Trends
Table 3. Adoptive Cellular Immunotherapy Market Drivers
Table 4. Adoptive Cellular Immunotherapy Market Challenges
Table 5. Adoptive Cellular Immunotherapy Market Restraints
Table 6. Global Adoptive Cellular Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Adoptive Cellular Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Adoptive Cellular Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Adoptive Cellular Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Adoptive Cellular Immunotherapy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Adoptive Cellular Immunotherapy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Adoptive Cellular Immunotherapy Revenue Share by Player, 2017-2022
Table 13. Global Adoptive Cellular Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adoptive Cellular Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular Immunotherapy as of 2021)
Table 15. Top Players of Adoptive Cellular Immunotherapy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Adoptive Cellular Immunotherapy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Adoptive Cellular Immunotherapy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Adoptive Cellular Immunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Adoptive Cellular Immunotherapy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Adoptive Cellular Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Adoptive Cellular Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Adoptive Cellular Immunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Adoptive Cellular Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Adoptive Cellular Immunotherapy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Adoptive Cellular Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Adoptive Cellular Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Adoptive Cellular Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Amgen Inc Company Details
Table 31. Amgen Inc Business Overview
Table 32. Amgen Inc Adoptive Cellular Immunotherapy Product
Table 33. Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 34. Amgen Inc Recent Development
Table 35. Autolus Therapeutics Plc Company Details
Table 36. Autolus Therapeutics Plc Business Overview
Table 37. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product
Table 38. Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 39. Autolus Therapeutics Plc Recent Development
Table 40. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 41. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 42. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product
Table 43. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 44. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 45. Bellicum Pharmaceuticals Inc Company Details
Table 46. Bellicum Pharmaceuticals Inc Business Overview
Table 47. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product
Table 48. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 49. Bellicum Pharmaceuticals Inc Recent Development
Table 50. Bristol-Myers Squibb Co Company Details
Table 51. Bristol-Myers Squibb Co Business Overview
Table 52. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product
Table 53. Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Co Recent Development
Table 55. bluebird bio Inc Company Details
Table 56. bluebird bio Inc Business Overview
Table 57. bluebird bio Inc Adoptive Cellular Immunotherapy Product
Table 58. bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 59. bluebird bio Inc Recent Development
Table 60. CARsgen Therapeutics Ltd Company Details
Table 61. CARsgen Therapeutics Ltd Business Overview
Table 62. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product
Table 63. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 64. CARsgen Therapeutics Ltd Recent Development
Table 65. Celgene Corp Company Details
Table 66. Celgene Corp Business Overview
Table 67. Celgene Corp Adoptive Cellular Immunotherapy Product
Table 68. Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 69. Celgene Corp Recent Development
Table 70. Cell Medica Ltd Company Details
Table 71. Cell Medica Ltd Business Overview
Table 72. Cell Medica Ltd Adoptive Cellular Immunotherapy Product
Table 73. Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 74. Cell Medica Ltd Recent Development
Table 75. Cellular Biomedicine Group Inc Company Details
Table 76. Cellular Biomedicine Group Inc Business Overview
Table 77. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product
Table 78. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 79. Cellular Biomedicine Group Inc Recent Development
Table 80. Celularity Inc Company Details
Table 81. Celularity Inc Business Overview
Table 82. Celularity Inc Adoptive Cellular Immunotherapy Product
Table 83. Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 84. Celularity Inc Recent Development
Table 85. Celyad SA Company Details
Table 86. Celyad SA Business Overview
Table 87. Celyad SA Adoptive Cellular Immunotherapy Product
Table 88. Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 89. Celyad SA Recent Development
Table 90. Daiichi Sankyo Co Ltd Company Details
Table 91. Daiichi Sankyo Co Ltd Business Overview
Table 92. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product
Table 93. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 94. Daiichi Sankyo Co Ltd Recent Development
Table 95. Fosun Pharmaceutical AG Company Details
Table 96. Fosun Pharmaceutical AG Business Overview
Table 97. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product
Table 98. Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 99. Fosun Pharmaceutical AG Recent Development
Table 100. Gilead Sciences Inc Company Details
Table 101. Gilead Sciences Inc Business Overview
Table 102. Gilead Sciences Inc Adoptive Cellular Immunotherapy Product
Table 103. Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 104. Gilead Sciences Inc Recent Development
Table 105. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 106. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 107. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product
Table 108. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 109. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 110. Hangzhou Converd Co Ltd Company Details
Table 111. Hangzhou Converd Co Ltd Business Overview
Table 112. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product
Table 113. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 114. Hangzhou Converd Co Ltd Recent Development
Table 115. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 116. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 117. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product
Table 118. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 119. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 120. HRAIN Biotechnology Co Ltd Company Details
Table 121. HRAIN Biotechnology Co Ltd Business Overview
Table 122. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product
Table 123. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 124. HRAIN Biotechnology Co Ltd Recent Development
Table 125. Juno Therapeutics Inc Company Details
Table 126. Juno Therapeutics Inc Business Overview
Table 127. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product
Table 128. Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 129. Juno Therapeutics Inc Recent Development
Table 130. Kite Pharma Inc Company Details
Table 131. Kite Pharma Inc Business Overview
Table 132. Kite Pharma Inc Adoptive Cellular Immunotherapy Product
Table 133. Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 134. Kite Pharma Inc Recent Development
Table 135. Nanjing Legend Biotech Co Ltd Company Details
Table 136. Nanjing Legend Biotech Co Ltd Business Overview
Table 137. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product
Table 138. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 139. Nanjing Legend Biotech Co Ltd Recent Development
Table 140. NantKwest Inc Company Details
Table 141. NantKwest Inc Business Overview
Table 142. NantKwest Inc Adoptive Cellular Immunotherapy Product
Table 143. NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 144. NantKwest Inc Recent Development
Table 145. Nkarta Inc Company Details
Table 146. Nkarta Inc Business Overview
Table 147. Nkarta Inc Adoptive Cellular Immunotherapy Product
Table 148. Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 149. Nkarta Inc Recent Development
Table 150. Novartis AG Company Details
Table 151. Novartis AG Business Overview
Table 152. Novartis AG Adoptive Cellular Immunotherapy Product
Table 153. Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 154. Novartis AG Recent Development
Table 155. Ono Pharmaceutical Co Ltd Company Details
Table 156. Ono Pharmaceutical Co Ltd Business Overview
Table 157. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product
Table 158. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 159. Ono Pharmaceutical Co Ltd Recent Development
Table 160. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 161. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 162. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product
Table 163. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 164. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table 165. Sorrento Therapeutics Inc Company Details
Table 166. Sorrento Therapeutics Inc Business Overview
Table 167. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product
Table 168. Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 169. Sorrento Therapeutics Inc Recent Development
Table 170. Takara Bio Inc Company Details
Table 171. Takara Bio Inc Business Overview
Table 172. Takara Bio Inc Adoptive Cellular Immunotherapy Product
Table 173. Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2017-2022) & (US$ Million)
Table 174. Takara Bio Inc Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Adoptive Cellular Immunotherapy Product Picture
Figure 2. Global Adoptive Cellular Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Adoptive Cellular Immunotherapy Market Size 2017-2028 (US$ Million)
Figure 4. United States Adoptive Cellular Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Adoptive Cellular Immunotherapy Market Size 2017-2028 (US$ Million)
Figure 6. United States Adoptive Cellular Immunotherapy Market Share in Global 2017-2028
Figure 7. Adoptive Cellular Immunotherapy Report Years Considered
Figure 8. Product Picture of TIL
Figure 9. Product Picture of LAK
Figure 10. Product Picture of CAR-T
Figure 11. Product Picture of TCR-T
Figure 12. Product Picture of CIK
Figure 13. Product Picture of NK
Figure 14. Product Picture of DC
Figure 15. Product Picture of Other
Figure 16. Global Adoptive Cellular Immunotherapy Market Share by Type in 2022 & 2028
Figure 17. Global Adoptive Cellular Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
Figure 18. Global Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
Figure 19. United States Adoptive Cellular Immunotherapy Market Share by Type in 2022 & 2028
Figure 20. United States Adoptive Cellular Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
Figure 21. United States Adoptive Cellular Immunotherapy Market Share by Type (2017-2028)
Figure 22. Product Picture of Hospital
Figure 23. Product Picture of Cancer Hospital
Figure 24. Product Picture of Centers for Disease Control and Prevention
Figure 25. Product Picture of Rehabilitation Center
Figure 26. Product Picture of Other
Figure 27. Global Adoptive Cellular Immunotherapy Market Share by Application in 2022 & 2028
Figure 28. Global Adoptive Cellular Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
Figure 29. Global Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
Figure 30. United States Adoptive Cellular Immunotherapy Market Share by Application in 2022 & 2028
Figure 31. United States Adoptive Cellular Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
Figure 32. United States Adoptive Cellular Immunotherapy Market Share by Application (2017-2028)
Figure 33. North America Adoptive Cellular Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. U.S. Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Canada Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Europe Adoptive Cellular Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. Germany Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. France Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. U.K. Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Italy Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Russia Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Asia-Pacific Adoptive Cellular Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 43. China Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Japan Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. South Korea Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. India Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Australia Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Taiwan Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Indonesia Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Thailand Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Malaysia Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Philippines Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Latin America Adoptive Cellular Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Mexico Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Brazil Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Argentina Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 58. Turkey Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 60. U.A.E Adoptive Cellular Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 61. Amgen Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 62. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 63. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 64. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 65. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 66. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 67. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 68. Celgene Corp Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 69. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 70. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 71. Celularity Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 72. Celyad SA Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 73. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 74. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 75. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 76. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 77. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 78. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 79. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 80. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 81. Kite Pharma Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 82. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 83. NantKwest Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 84. Nkarta Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 85. Novartis AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 86. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 87. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 88. Sorrento Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 89. Takara Bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2017-2022)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc Autolus Therapeutics Plc Beijing Immunochina Medical Science & Technology Co Ltd Bellicum Pharmaceuticals Inc Bristol-Myers Squibb Co bluebird bio Inc CARsgen Therapeutics Ltd Celgene Corp Cell Medica Ltd Cellular Biomedicine Group Inc Celularity Inc Celyad SA Daiichi Sankyo Co Ltd Fosun Pharmaceutical AG Gilead Sciences Inc Guangzhou Anjie Biomedical Technology Co Ltd Hangzhou Converd Co Ltd Hebei Senlang Biotechnology Inc Ltd HRAIN Biotechnology Co Ltd Juno Therapeutics Inc Kite Pharma Inc Nanjing Legend Biotech Co Ltd NantKwest Inc Nkarta Inc Novartis AG Ono Pharmaceutical Co Ltd Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Sorrento Therapeutics Inc Takara Bio Inc